Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How NICE may be outflanked.

Authors: Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal: CMAJ Date: 2004-02-17 Impact factor: 8.262

7. Newly licensed drugs.

Authors: R E Ferner
Journal: BMJ Date: 1996-11-09

8. The tragedy of the commons. The population problem has no technical solution; it requires a fundamental extension in morality.

Authors: G Hardin
Journal: Science Date: 1968-12-13 Impact factor: 47.728

9. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews.

Authors: Trevor A Sheldon; Nicky Cullum; Diane Dawson; Annette Lankshear; Karin Lowson; Ian Watt; Peter West; Dianne Wright; John Wright
Journal: BMJ Date: 2004-10-30

10. Increasing use of a new health technology during the wait for NICE guidance: findings from the third national tracker survey of photodynamic therapy.

Authors: Barny Foot; Robbie Foy; Usha Chakravarthy; Richard Wormald
Journal: J Public Health (Oxf) Date: 2004-03 Impact factor: 2.341

13 in total

1. NICE work: nice try.

Authors: Sam Shuster
Journal: BMJ Date: 2006-06-10

2. NICE work: level playing field requires transparency.

Authors: Rubin Minhas
Journal: BMJ Date: 2006-06-10

3. Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test.

Authors: Nikolaos P Polyzos; Antonis Valachis; Davide Mauri; John P A Ioannidis
Journal: CMAJ Date: 2011-03-14 Impact factor: 8.262

4. Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage.

Authors: Paul M Wilson; Alison M Booth; Alison Eastwood; Ian S Watt
Journal: J R Soc Med Date: 2008-03 Impact factor: 5.344

5. Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs?

Authors: David Hughes; Bryn Williams-Jones
Journal: Healthc Policy Date: 2013-08

6. Media influence on Herceptin subsidization in Australia: application of the rule of rescue?

Authors: Ross Mackenzie; Simon Chapman; Glenn Salkeld; Simon Holding
Journal: J R Soc Med Date: 2008-06 Impact factor: 5.344

Review 7. External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer.

Authors: Christopher M Booth; George Dranitsaris; M Corona Gainford; Scott Berry; Michael Fralick; John Fralick; Joanna Sue; Mark Clemons
Journal: BMC Cancer Date: 2007-06-28 Impact factor: 4.430

Review 8. When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.

Authors: Ferrán Catalá-López; Gabriel Sanfélix-Gimeno; Manuel Ridao; Salvador Peiró
Journal: PLoS One Date: 2013-07-08 Impact factor: 3.240

9. Academics and competing interests in H1N1 influenza media reporting.

Authors: Kate L Mandeville; Sam O'Neill; Andrew Brighouse; Alice Walker; Kielan Yarrow; Kenneth Chan
Journal: J Epidemiol Community Health Date: 2013-11-11 Impact factor: 3.710

10. The impact of cancer research: how publications influence UK cancer clinical guidelines.

Authors: G Lewison; R Sullivan
Journal: Br J Cancer Date: 2008-06-03 Impact factor: 7.640